To show that reverse Hybrid therapy is as efficacious in eradication of helicobacter pylori infection as concomitant therapy with fewer adverse events and better compliance
Not Applicable
- Conditions
- Health Condition 1: K27- Peptic ulcer, site unspecified
- Registration Number
- CTRI/2021/11/038336
- Lead Sponsor
- JIPMER
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Who have undergone upper gastrointestinal endoscopy in department of surgery with helicobacter pylori infection and need eradication
Exclusion Criteria
Patients who have received previous eradication therapy
Patients who have had previous history of allergy to any antibiotic of our study
Patients who have undergone previous gastric Tommy
Patients with coexisting severe concomitant illness
Pregnant or lactating women
Patients who used antibiotics in the previous 4 weeks
Patients diagnosed with any malignancies
Patients with portal gastropathy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method